학술논문
Evaluation of 5-(Trifluoromethyl)-1,2,4-oxadiazole-Based Class IIa HDAC Inhibitors for Huntington's Disease
Document Type
Article
Author
Stott, A.J.; Allcock, D.; Aziz, O.; Blackaby, W.; Breccia, P.; Creighton-Gutteridge, G.; Haughan, A.F.; Jarvis, R.E.; Luckhurst, C.A.; Matthews, K.L.; McAllister, G.; Pollack, S.; Saville-Stones, E.; Van De Poël, A.J.; Vater, H.D.; Vann, J.; Williams, R.; Yates, D.; Maillard, M.C.; Beaumont, V.; Borchers, A.H.; Muñoz-Sanjuán, I.; Dominguez, C.
Source
In: ACS Medicinal Chemistry Letters . (ACS Medicinal Chemistry Letters, 11 March 2021, 12(3):380-388)
Subject
Language
English
ISSN
19485875